ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,785Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 439

$529K Total Retail Price of All Prescriptions

Rank: 63 out of 439

316 Patients Receiving at Least One Drug in Part D
58%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 316 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

19% of this provider’s 316 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 5,299 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
AMLODIPINE BESYLATE 371 294 1 2
HYDROCODONE-ACETAMINOPHEN 317 124 S3 2 1
SIMVASTATIN 245 168 3 3
METFORMIN HCL 219 160 4 29
FUROSEMIDE 209 154 5 5
HYDROCHLOROTHIAZIDE 171 139 6 18
GABAPENTIN 148 50 7 7
TRAMADOL HCL 147 84 8 21
PRAVASTATIN SODIUM 140 90 9 23
CARVEDILOL 115 62 10 8
OMEPRAZOLE 113 64 11 6
MELOXICAM 110 91 12 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 110 53 12 63
METOPROLOL TARTRATE 108 87 14 11
LISINOPRIL 107 90 15 4
DIOVAN HCT 106 69 16 128
JANUVIA 104 71 17 113
NEXIUM 103 67 18 32
ATORVASTATIN CALCIUM 101 75 19 12
LEVOTHYROXINE SODIUM 100 67 20 9
CLONIDINE HCL 94 30 21 47
FLUTICASONE PROPIONATE 90 34 22 50
ZOLPIDEM TARTRATE 90 55 22 14
CARISOPRODOL 85 27 R 24 19
DIOVAN 83 75 25 65
RANITIDINE HCL 82 36 26 39
GLIPIZIDE ER 81 56 27 190
TRAZODONE HCL 77 36 28 35
OXYCODONE HCL-ACETAMINOPHEN 77 0 S2 28 37
CITALOPRAM HBR 74 30 30 34
PROAIR HFA 73 38 31 53
CYCLOBENZAPRINE HCL 72 21 R 32 49
INSULIN SYRINGE 71 50 33 78
PLAVIX 70 47 34 26
AMOX TR-POTASSIUM CLAVULANATE 70 40 34 212
FAMOTIDINE 68 32 36 69
CLOPIDOGREL 68 38 36 16
ALLOPURINOL 64 39 38 54
LOSARTAN-HYDROCHLOROTHIAZIDE 63 36 39 91
PANTOPRAZOLE SODIUM 62 51 40 60
COLCRYS 61 46 41 201
PROMETHAZINE HCL 59 20 R 42 68
ACETAMINOPHEN-CODEINE 58 43 S3 43 249
ESTRADIOL 58 39 R 43 89
CYMBALTA 57 30 45 45
CRESTOR 56 20 46 33
OXYCODONE-ACETAMINOPHEN 56 34 S2 46 66
GLIPIZIDE 54 52 48 120
BENAZEPRIL HCL 54 31 48 130
DICLOFENAC SODIUM 54 28 48 125
BENICAR HCT 52 26 51 255
LANTUS 51 32 52 85
SERTRALINE HCL 50 16 53 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.